Skip to main content
Journal of Patient-Reported Outcomes
Fig. 3 | Journal of Patient-Reported Outcomes

Fig. 3

From: Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy

Fig. 3

Duration of therapy in ePRO cohort users vs non-users. a index IO regimen and b subsequent regimen. aPatients whose end of follow-up date (eg, date of last contact with TO) was on their index date were excluded from the analytical subset (no observed follow-up time), as were patients with unknown line of therapy start or end dates. Kaplan-Meier curves were truncated at 6 months from the index date, the maximum observation period. Shaded areas around the curves represent 95% CIs. CI confidence interval; ePRO electronic patient-reported outcome; IO immuno-oncology; NE not estimable; Pts patients; TO Tennessee oncology

Back to article page